In retrospect it was a mistake letting Lonza do the manufacturing for Gamida. This was one of the reasons for the FDA delay in the approval. Too bad Gamida has had to pay this substantial amount for the vreach of contract, the positive point is that the burden is off their shoulders, and it seems the road to FDA final approval in coming May is paved smooth.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.